2F-DCK 100 MG Pellety
2F-DCK 100 MG Pellety Zakres cen: od €34.95 do €1,189.95
Powrót do produktów
RC+ 4-Fluor 120 mg Blister
RC+ 4-Fluor 120 mg Blister €20.57
DCK (Deschloroketamine) - obrazek 1
DCK (Deschloroketamine) - obrazek 2

DCK (Deschloroketamina)

DCK properties

Synonim: 2′-okso-PCM, deschloroketamina
Numer CAS: 4631-27-0
Formuła: 2-(metyloamino)-2-fenylo-cykloheksanon
Masa molowa: 239.7 g/mol
Czystość: >97%

Zakres cen: od €22.95 do €2,599.95

Dodaj do porównania
Dodaj do listy życzeń
OSZCZĘDŹ 15%

więcej 2 produkty

OSZCZĘDŹ 50%

6 w cenie 3

* Informacje na tej stronie stanowią podsumowanie i nie obejmują wszystkich dostępnych informacji na temat tego leku. Nie obejmują one wszystkich możliwych zastosowań, sposobów użycia, środków ostrożności, interakcji z innymi lekami ani działań niepożądanych i nie zastępują wiedzy i osądu lekarza.

Product Definition: DCK (Deschloroketamine) Research Chemicals

Nazwa chemiczna:  Chlorowodorek deschloroketaminy
Synonimy:  DCK, 2′-Okso-PCM
Wzór cząsteczkowy:  C13H16NO•HCl
Masa cząsteczkowa:  229,73 g/mol
CAS No.:  7061-51-4
Appearance:  White crystalline powder
Czystość:  ≥98% (HPLC verified)
Rozpuszczalność:  50 mg/ml w wodzie

Description & Pharmacology:
DCK is a ketamine analog with potent NMDA receptor antagonism. This study substance exhibits:
✔Longer duration of action than ketamine (4-6 hours)
✔Potent dissociative properties
✔Potential antidepressant activity
✔Lower bladder toxicity than ketamine

Research applications:

  1. Neuroscientific research into:

    • NMDA receptor function

    • Rapid antidepressant mechanisms

    • Neuroplasticity

  2. Anesthesiological studies:

    • Dissociative anesthetics

    • Pain perception modulation

  3. Psychopharmacology:

    • Consciousness-altering effects

    • Dissociative states

Benefits for Research:
✅ Higher potency than ketamine (2-3x)
✅Longer duration of action (ideal for studies)
✅Less hepatotoxic than some analogs
✅Good oral bioavailability

Risks & Limitations:
❌ Possible side effects:

  • Hypertension

  • Disorientation

  • Nausea
    ❌Limited long-term studies available
    ❌Potential for dissociative episodes

Dosage protocol (for research):

Target levelDosage (oral)Expected effect
Mikrodawka5-10 mgSubtle effects
Standard15-30 mgClear dissociation
Wysoki30-50 mgStrong dissociative state

Safety measures:

  • Do not combine with:
    • MAO inhibitors
    • Other NMDA antagonists
    • CNS depressants

  • At least 1 week between examinations

Frequently Asked Questions:

  1. Is DCK legal in the Netherlands?
    DCK may fall under the Opium Act as a ketamine analogue.

  2. How does DCK differ from ketamine?
    Longer duration of action, higher potency, less bladder irritation.

  3. Can DCK be addictive?
    Frequent use can lead to tolerance.

  4. Is DCK detected in drug tests?
    It can cross-react with ketamine tests.

Quality Control & Analytical Data:

Specifications:

  • Purity: ≥98% (HPLC)

  • Heavy metals: <2 ppm

  • Microbiology: <100 CFU/g

  • Residual solvents: <0.1%

Stability data:

  • Shelf life: 24 months at 15-25°C

  • Light sensitivity: Moderate

  • Moisture sensitivity: High

Conclusion:
DCK offers valuable research opportunities for neuroscience and pharmacological studies, but requires strict ethical protocols.

⚠ For in vitro research only – not for human consumption

Wskazówki dotyczące przechowywania:

  • Airtight packaging

  • Store in a dark place

  • Dry at <25°C

Ethical considerations: